| |
| |
|
| Insider
Information: |
Miller Richard A Md |
| Relationship: |
Director |
| City: |
Sunnyvale |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
351,446 |
|
|
Indirect Shares
|
1,516,787 |
|
|
| Direct
Value |
$72,597 |
|
|
|
Indirect Value
|
$2,309,684 |
|
|
| Total
Shares |
1,868,233 |
|
|
| Total
Value |
$2,382,281 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
14
|
0
|
|
Stock
price went up :
|
5
|
0
|
| Stock
price went down : |
9
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 43.7%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Pharmacyclics Inc |
PCYC |
Pres, CEO & Director, ... |
2007-08-22 |
300,130 |
2007-08-22 |
26,668 |
Premium* |
|
|
Corvus Pharmaceuticals, Inc. |
CRVS |
President and CEO, Dir... |
2022-09-28 |
35,714 |
2022-12-14 |
1,490,119 |
Premium* |
|
|
Bolt Biotherapeutics, Inc. |
BOLT |
Director |
2021-02-04 |
15,602 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CRVS |
Corvus Pharmaceuticals, I... |
President and CEO |
• • – |
2022-12-14 |
4 |
B |
$0.78 |
$7,812 |
I/I |
10,000 |
1,490,119 |
2.58 |
% |
|
| CRVS |
Corvus Pharmaceuticals, I... |
President and CEO |
• • – |
2022-12-13 |
4 |
B |
$0.74 |
$37,015 |
I/I |
50,000 |
1,480,119 |
2.66 |
% |
|
| CRVS |
Corvus Pharmaceuticals, I... |
President and CEO |
• • – |
2022-09-28 |
4 |
B |
$0.76 |
$19,070 |
I/I |
25,000 |
1,394,405 |
2.58 |
% |
|
| CRVS |
Corvus Pharmaceuticals, I... |
President and CEO |
• • – |
2022-09-20 |
4 |
B |
$0.81 |
$16,253 |
I/I |
20,000 |
1,369,405 |
2.58 |
% |
|
| CRVS |
Corvus Pharmaceuticals, I... |
President and CEO |
• • – |
2022-06-27 |
4 |
B |
$1.00 |
$4,985 |
I/I |
5,000 |
1,349,405 |
2.58 |
% |
|
| CRVS |
Corvus Pharmaceuticals, I... |
President and CEO |
• • – |
2022-06-24 |
4 |
B |
$1.03 |
$5,150 |
I/I |
5,000 |
1,344,405 |
2.58 |
% |
|
| CRVS |
Corvus Pharmaceuticals, I... |
President and CEO |
• • – |
2022-06-06 |
4 |
B |
$1.01 |
$899 |
I/I |
890 |
1,339,405 |
2.58 |
% |
|
| CRVS |
Corvus Pharmaceuticals, I... |
President and CEO |
• • – |
2022-06-02 |
4 |
B |
$0.97 |
$4,898 |
I/I |
5,000 |
1,338,515 |
2.58 |
% |
|
| CRVS |
Corvus Pharmaceuticals, I... |
President and CEO |
• • – |
2022-03-31 |
4 |
B |
$1.64 |
$24,534 |
I/I |
15,000 |
1,333,515 |
2.58 |
% |
|
| CRVS |
Corvus Pharmaceuticals, I... |
President and CEO |
• • – |
2022-03-17 |
4 |
B |
$1.59 |
$7,950 |
I/I |
5,000 |
1,318,515 |
2.58 |
% |
|
| CRVS |
Corvus Pharmaceuticals, I... |
President and CEO |
• • – |
2022-03-15 |
4 |
B |
$1.47 |
$36,650 |
I/I |
25,000 |
1,313,515 |
2.66 |
% |
|
| CRVS |
Corvus Pharmaceuticals, I... |
President and CEO |
• • – |
2021-08-20 |
4 |
B |
$1.93 |
$19,254 |
I/I |
10,000 |
1,288,515 |
2.58 |
% |
|
| CRVS |
Corvus Pharmaceuticals, I... |
President and CEO |
• • – |
2021-05-04 |
4 |
B |
$2.80 |
$99,999 |
D/D |
35,714 |
35,714 |
2.81 |
% |
|
| CRVS |
Corvus Pharmaceuticals, I... |
President and CEO |
• • – |
2021-02-17 |
4 |
B |
$3.50 |
$350,000 |
I/I |
100,000 |
1,278,515 |
2.66 |
% |
|
| BOLT |
Bolt Biotherapeutics, Inc... |
Director |
– • – |
2021-02-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
15,602 |
|
- |
|
| CRVS |
Corvus Pharmaceuticals, I... |
President and CEO |
• • – |
2019-11-13 |
4 |
B |
$3.00 |
$44,240 |
I/I |
14,736 |
1,178,515 |
2.66 |
- |
|
| CRVS |
Corvus Pharmaceuticals, I... |
President and CEO |
• • – |
2019-11-12 |
4 |
B |
$2.90 |
$789 |
I/I |
272 |
1,163,779 |
2.58 |
- |
|
| CRVS |
Corvus Pharmaceuticals, I... |
President and CEO |
• • – |
2019-08-07 |
4 |
B |
$3.54 |
$8,850 |
I/I |
2,500 |
1,163,507 |
2.58 |
- |
|
| CRVS |
Corvus Pharmaceuticals, I... |
President and CEO |
• • – |
2019-08-06 |
4 |
B |
$3.58 |
$17,875 |
I/I |
5,000 |
1,161,007 |
2.58 |
- |
|
| CRVS |
Corvus Pharmaceuticals, I... |
President and CEO |
• • – |
2019-06-14 |
4 |
B |
$3.40 |
$39,666 |
I/I |
11,657 |
1,156,007 |
2.66 |
- |
|
| CRVS |
Corvus Pharmaceuticals, I... |
President and CEO |
• • – |
2019-06-13 |
4 |
B |
$3.52 |
$1,207 |
I/I |
343 |
1,144,350 |
2.58 |
- |
|
| CRVS |
Corvus Pharmaceuticals, I... |
President and CEO |
• • – |
2019-06-11 |
4 |
B |
$3.67 |
$22,020 |
I/I |
6,000 |
1,144,007 |
2.58 |
- |
|
| CRVS |
Corvus Pharmaceuticals, I... |
President and CEO |
• • – |
2019-06-07 |
4 |
B |
$3.37 |
$31,019 |
I/I |
9,212 |
1,138,007 |
2.66 |
- |
|
| CRVS |
Corvus Pharmaceuticals, I... |
President and CEO |
• • – |
2018-12-27 |
4 |
B |
$3.29 |
$65,884 |
I/I |
20,000 |
1,128,795 |
2.66 |
- |
|
| CRVS |
Corvus Pharmaceuticals, I... |
President and CEO |
• • – |
2018-12-20 |
4 |
B |
$4.39 |
$43,950 |
I/I |
10,000 |
1,108,795 |
2.66 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
